Burford Capital Logo Light Burford Capital Logo Dark

Unlocking the value of pharmaceutical IP assets

June 28, 2022
Joshua Harris

Summary

Outside capital has powerful applications for pharma brands, universities and generics manufacturers seeking to de-risk and pursue valuable IP assets, and may spell the difference between success and failure in costly and protracted patent suits.

In the past decade IP litigation has grown more costly and risky,1 but none more so than pharmaceutical patent litigation. Unlike ordinary IP disputes, the complexity of pharmaceutical patents and associated regulatory hurdles amplify risk. And even if a claiman…

Provide your information below to view this page.

The latest from Burford

Read all
Burford Quarterly Visualizing 15 years of legal finance
Burford Quarterly Expert insights: Construction dispute trends Jeffery Commission, Joe Durkin
Burford Quarterly The business trends driving high-value commercial disputes in the US healthcare sector Charles Griffin, Greg McPolin

Get in touch

We welcome inquiries about Burford financing and other ways Burford can help clients and law firms. Please click the button below to complete a contact form or email us directly.

Contact Us

This site uses non-essential cookies to provide you with a personalized browsing experience.  We also use analytical cookies to help us improve our website by collecting and reporting information on its usage. By using this site you agree to our use of cookies as explained in our Privacy Policy. Please read our Privacy Policy for more information on how we use cookies and how you can manage them.

Accept cookies Decline cookies